XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2013-12-30: Form 6-K; Period of report 2013-12-30; Description FORM 6-K; Document v364197_6-k.htm.
- 2013-12-18: Form 6-K; Period of report 2013-12-18; Description FORM 6-K; Document v363383_6k.htm.
- 2013-12-17: Form 6-K; Period of report 2013-12-17; Description FORM 6-K; Document v363277_6k.htm.
- 2013-12-16: Form 6-K; Period of report 2013-12-16; Description FORM 6-K; Document v363156_6-k.htm.